Paper Details

  1. Home
  2. Paper Details

Safety concerns and risk management of multiple sclerosis therapies.

Author: Soelberg SorensenP

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This article provides an overview of treatment options for relapsing-remitting multiple sclerosis (MS). It discusses the efficacy and safety profiles of various drugs, including interferon-β preparations, glatiramer acetate, teriflunomide, dimethyl fumarate, fingolimod, natalizumab, daclizumab, and alemtuzumab. It highlights the importance of personalized treatment decisions based on individual patient factors and risk-benefit considerations.
Paper Details　
Original Abstract of the Article :
Currently, more than ten drugs have been approved for treatment of relapsing-remitting multiple sclerosis (MS). Newer treatments may be more effective, but have less favorable safety record. Interferon-β preparations and glatiramer acetate treatment require frequent subcutaneous or intramuscular inj...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/ane.12712

データ提供：米国国立医学図書館（NLM）

Navigating the Complex Landscape of Multiple Sclerosis Treatments: A Balancing Act of Benefits and Risks

This study dives into the complex world of multiple sclerosis (MS) treatment, where a multitude of drugs are available, each with its own unique profile of benefits and risks. Imagine a camel caravan traversing a vast desert landscape. Each camel is equipped with different skills and abilities, but some are better suited for specific challenges than others. Similarly, each MS treatment offers different advantages but also carries potential side effects.

Balancing the Scales: Choosing the Right MS Treatment

The study emphasizes the importance of individualized treatment decisions, considering the specific needs and circumstances of each patient. The choice of treatment should be based on a careful evaluation of potential benefits versus risks, much like a camel caravan choosing the safest and most efficient route through the desert.

A Collaborative Approach to MS Management

The authors highlight the importance of open communication and collaboration between patients and their neurologists to make informed decisions about treatment. It is a journey that requires teamwork, just as a camel caravan relies on the cooperation of its members to reach its destination safely and successfully.

Dr. Camel's Conclusion

Navigating the world of MS treatment is like navigating a vast and unpredictable desert. With careful planning and open communication, patients can find the best path forward, just as a well-organized camel caravan can conquer any terrain.

Date :
  1. Date Completed 2018-03-26
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

27891572

DOI: Digital Object Identifier

10.1111/ane.12712

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.